Published in Strahlenther Onkol on January 01, 2008
Recent advances in image-guided radiotherapy for head and neck carcinoma. J Oncol (2009) 0.96
A strategy for the use of image-guided radiotherapy (IGRT) on linear accelerators and its impact on treatment margins for prostate cancer patients. Strahlenther Onkol (2008) 0.93
A planning comparison of dynamic IMRT for different collimator leaf thicknesses with helical tomotherapy and RapidArc for prostate and head and neck tumors. Strahlenther Onkol (2010) 0.93
Tumor shrinkage assessed by volumetric MRI in the long-term follow-up after stereotactic radiotherapy of meningiomas. Strahlenther Onkol (2010) 0.91
Quality Control of Portal Imaging with PTW EPID QC PHANTOM. Strahlenther Onkol (2009) 0.91
Immediate reconstruction with an expander/implant following ablatio mammae because of breast cancer : side effects and cosmetic results after adjuvant chest wall radiotherapy. Strahlenther Onkol (2009) 0.90
Dose escalation in prostate radiotherapy up to 82 Gy using simultaneous integrated boost: direct comparison of acute and late toxicity with 3D-CRT 74 Gy and IMRT 78 Gy. Strahlenther Onkol (2010) 0.90
Highly cited German research contributions to the fields of radiation oncology, biology, and physics: focus on collaboration and diversity. Strahlenther Onkol (2012) 0.89
Radiotherapy and chemotherapy as therapeutic strategies in extrahepatic biliary duct carcinoma. Strahlenther Onkol (2010) 0.89
Moderate dose escalation in three-dimensional conformal localized prostate cancer radiotherapy: single-institutional experience in 398 patients comparing 66 Gy versus 70 Gy versus 74 Gy. Strahlenther Onkol (2009) 0.89
Reirradiation with alternating docetaxel-based chemotherapy for recurrent head and neck squamous cell carcinoma: update of a single-center prospective phase II protocol. Strahlenther Onkol (2010) 0.87
Intensity modulated radiotherapy (IMRT) in the treatment of children and adolescents--a single institution's experience and a review of the literature. Radiat Oncol (2009) 0.87
Is helical tomotherapy accurate and safe enough for spine stereotactic body radiotherapy? J Cancer Res Clin Oncol (2012) 0.87
PET-guided dose escalation tomotherapy in malignant pleural mesothelioma. Strahlenther Onkol (2011) 0.86
Helical tomotherapy for spine oligometastases from gastrointestinal malignancies. Radiat Oncol J (2011) 0.86
Reirradiation of multiple brain metastases with helical tomotherapy. A multifocal simultaneous integrated boost for eight or more lesions. Strahlenther Onkol (2009) 0.86
Increasing frequency of reirradiation studies in radiation oncology: systematic review of highly cited articles. Am J Cancer Res (2013) 0.86
Dosimetric selection for helical tomotherapy based stereotactic ablative radiotherapy for early-stage non-small cell lung cancer or lung metastases. PLoS One (2012) 0.84
Outcome and prognostic factors of desmoplastic medulloblastoma treated within a multidisciplinary treatment concept. BMC Cancer (2010) 0.84
Using cone-beam computed tomography to evaluate the impact of bladder filling status on target position in prostate radiotherapy. Strahlenther Onkol (2009) 0.84
Tomotherapy radiosurgery for arteriovenous malformations--current possibilities and future options with helical tomotherapy dynamic jaws? Technol Cancer Res Treat (2013) 0.83
Dosimetric comparison of image guidance by megavoltage computed tomography versus bone alignment for prostate cancer radiotherapy. Strahlenther Onkol (2009) 0.83
Computed tomography as a source of electron density information for radiation treatment planning. Strahlenther Onkol (2010) 0.83
Moderate risk-adapted dose escalation with three-dimensional conformal radiotherapy of localized prostate cancer from 70 to 74 Gy. First report on 5-year morbidity and biochemical control from a prospective Austrian-German multicenter phase II trial. Strahlenther Onkol (2009) 0.83
Additive effects of 5-aza-2'-deoxycytidine and irradiation on clonogenic survival of human medulloblastoma cell lines. Strahlenther Onkol (2009) 0.82
A dosimetric selectivity intercomparison of HDR brachytherapy, IMRT and helical tomotherapy in prostate cancer radiotherapy. Strahlenther Onkol (2009) 0.81
Pattern of failure after helical tomotherapy in head and neck cancer. Strahlenther Onkol (2010) 0.81
[First results of the federal quality assurance group ("Arztliche Stelle") in radiotherapy in baden-württemberg: part 1]. Strahlenther Onkol (2009) 0.80
Surface dose in the treatment of breast cancer with helical tomotherapy. Strahlenther Onkol (2009) 0.80
The value of image-guided intensity-modulated radiotherapy in challenging clinical settings. Br J Radiol (2013) 0.79
Superiority of conventional intensity-modulated radiotherapy over helical tomotherapy in locally advanced non-small cell lung cancer. A comparative plan analysis. Strahlenther Onkol (2012) 0.79
Prospective study on the dose distribution to the acoustic structures during postoperative 3D conformal radiotherapy for parotid tumors: dosimetric and audiometric aspects. Strahlenther Onkol (2011) 0.79
[Automated delivery of codes for charge in radiotherapy]. Strahlenther Onkol (2010) 0.78
Impact of (18)F-FDG-PET/CT on staging and irradiation of patients with locally advanced rectal cancer. Strahlenther Onkol (2009) 0.77
Technical considerations for noncoplanar proton-beam therapy of patients with tumors proximal to the optic nerve. Strahlenther Onkol (2009) 0.77
Prognostic impact of VEGF and VEGF receptor 1 (FLT1) expression in patients irradiated for stage II/III non-small cell lung cancer (NSCLC). Strahlenther Onkol (2010) 0.77
Image guidance protocols: balancing imaging parameters against scan time. Br J Radiol (2013) 0.77
Helical tomotherapy with concurrent capecitabine for the treatment of inoperable pancreatic cancer. Radiat Oncol (2010) 0.76
The effect of adjuvant radiotherapy on mortality differs according to primary tumor location in women with node-positive breast cancer. Strahlenther Onkol (2009) 0.76
Hypofractionated helical intensity-modulated radiotherapy of the prostate bed after prostatectomy with or without the pelvic lymph nodes - the PRIAMOS trial. BMC Cancer (2012) 0.75
Craniospinal irradiation using helical tomotherapy for central nervous system tumors. J Radiat Res (2017) 0.75
Colorectal cancer. Lancet (2005) 4.90
Comparison of PET imaging with a (68)Ga-labelled PSMA ligand and (18)F-choline-based PET/CT for the diagnosis of recurrent prostate cancer. Eur J Nucl Med Mol Imaging (2013) 3.61
The diagnostic value of PET/CT imaging with the (68)Ga-labelled PSMA ligand HBED-CC in the diagnosis of recurrent prostate cancer. Eur J Nucl Med Mol Imaging (2014) 3.40
Reduced treatment intensity in patients with early-stage Hodgkin's lymphoma. N Engl J Med (2010) 2.97
Changes in salivary gland function after radiotherapy of head and neck tumors measured by quantitative pertechnetate scintigraphy: comparison of intensity-modulated radiotherapy and conventional radiation therapy with and without Amifostine. Int J Radiat Oncol Biol Phys (2006) 2.48
Open-label, multicenter, randomized phase III trial of adjuvant chemoradiation plus interferon Alfa-2b versus fluorouracil and folinic acid for patients with resected pancreatic adenocarcinoma. J Clin Oncol (2012) 1.90
Surgery for recurrent pancreatic ductal adenocarcinoma. Ann Surg (2007) 1.85
Transcriptional network governing the angiogenic switch in human pancreatic cancer. Proc Natl Acad Sci U S A (2007) 1.85
Trimodal cancer treatment: beneficial effects of combined antiangiogenesis, radiation, and chemotherapy. Cancer Res (2005) 1.62
Improvement of surgical results for pancreatic cancer. Lancet Oncol (2013) 1.60
Efficacy of fractionated stereotactic reirradiation in recurrent gliomas: long-term results in 172 patients treated in a single institution. J Clin Oncol (2005) 1.60
Effectiveness of carbon ion radiotherapy in the treatment of skull-base chordomas. Int J Radiat Oncol Biol Phys (2007) 1.56
Radiochemotherapy in patients with primary glioblastoma comparing two temozolomide dose regimens. Int J Radiat Oncol Biol Phys (2008) 1.55
Intracellular visualization of prostate cancer using magnetic resonance imaging. Cancer Res (2003) 1.52
Results of carbon ion radiotherapy in 152 patients. Int J Radiat Oncol Biol Phys (2004) 1.51
Evaluation of salivary gland function after treatment of head-and-neck tumors with intensity-modulated radiotherapy by quantitative pertechnetate scintigraphy. Int J Radiat Oncol Biol Phys (2004) 1.50
Multidisciplinary pain management based on a computerized clinical decision support system in cancer pain patients. Pain (2009) 1.48
Intensified chemotherapy and dose-reduced involved-field radiotherapy in patients with early unfavorable Hodgkin's lymphoma: final analysis of the German Hodgkin Study Group HD11 trial. J Clin Oncol (2010) 1.46
A new concept for interactive radiotherapy planning with multicriteria optimization: first clinical evaluation. Radiother Oncol (2007) 1.45
Radiation dosimetry and first therapy results with a (124)I/ (131)I-labeled small molecule (MIP-1095) targeting PSMA for prostate cancer therapy. Eur J Nucl Med Mol Imaging (2014) 1.43
Analysis of intrathoracic tumor mobility during whole breathing cycle by dynamic MRI. Int J Radiat Oncol Biol Phys (2004) 1.41
External beam radiotherapy in the treatment of male breast carcinoma: patterns of failure in a single institute experience. Tumori (2005) 1.40
4D-CT-based target volume definition in stereotactic radiotherapy of lung tumours: comparison with a conventional technique using individual margins. Radiother Oncol (2009) 1.39
Long-term survival of cancer patients compared to heart failure and stroke: a systematic review. BMC Cancer (2010) 1.38
Combination of vascular endothelial growth factor receptor/platelet-derived growth factor receptor inhibition markedly improves radiation tumor therapy. Clin Cancer Res (2008) 1.36
Carbon ion radiotherapy of skull base chondrosarcomas. Int J Radiat Oncol Biol Phys (2006) 1.33
Stereotactic single-dose radiotherapy (radiosurgery) of early stage nonsmall-cell lung cancer (NSCLC). Cancer (2007) 1.31
Neoadjuvant chemoradiation with Gemcitabine for locally advanced pancreatic cancer. Radiat Oncol (2012) 1.28
Assessment of focal liver reaction by multiphasic CT after stereotactic single-dose radiotherapy of liver tumors. Int J Radiat Oncol Biol Phys (2003) 1.27
Characterization of 68Ga-DOTA-D-Phe1-Tyr3-octreotide kinetics in patients with meningiomas. J Nucl Med (2005) 1.25
Rotational IMRT techniques compared to fixed gantry IMRT and tomotherapy: multi-institutional planning study for head-and-neck cases. Radiat Oncol (2011) 1.25
Outcome and late complications of radiotherapy in patients with unicentric Castleman disease. Acta Oncol (2006) 1.24
Effectiveness of cetuximab/gefitinib in the therapy of a sacral chordoma. Onkologie (2006) 1.24
Re-resection for isolated local recurrence of pancreatic cancer is feasible, safe, and associated with encouraging survival. Ann Surg Oncol (2012) 1.21
Fractionated stereotactic radiotherapy in patients with benign or atypical intracranial meningioma: long-term experience and prognostic factors. Int J Radiat Oncol Biol Phys (2005) 1.20
Hypofractionated carbon ion therapy delivered with scanned ion beams for patients with hepatocellular carcinoma - feasibility and clinical response. Radiat Oncol (2013) 1.19
Particle therapy at the Heidelberg Ion Therapy Center (HIT) - Integrated research-driven university-hospital-based radiation oncology service in Heidelberg, Germany. Radiother Oncol (2010) 1.18
Postoperative treatment of primary glioblastoma multiforme with radiation and concomitant temozolomide in elderly patients. Int J Radiat Oncol Biol Phys (2007) 1.18
A biological transporter for the delivery of peptide nucleic acids (PNAs) to the nuclear compartment of living cells. J Mol Biol (2002) 1.18
Treatment of brain metastases from non-small-cell lung cancer (NSCLC): radiotherapy. Lung Cancer (2004) 1.17
Accuracy of a commercial optical 3D surface imaging system for realignment of patients for radiotherapy of the thorax. Phys Med Biol (2007) 1.16
Radiotherapeutic alternatives for previously irradiated recurrent gliomas. BMC Cancer (2007) 1.15
4D-MRI analysis of lung tumor motion in patients with hemidiaphragmatic paralysis. Radiother Oncol (2009) 1.13
Improved target volume definition for fractionated stereotactic radiotherapy in patients with intracranial meningiomas by correlation of CT, MRI, and [68Ga]-DOTATOC-PET. Int J Radiat Oncol Biol Phys (2006) 1.11
Assessment of irradiated brain metastases by means of arterial spin-labeling and dynamic susceptibility-weighted contrast-enhanced perfusion MRI: initial results. Invest Radiol (2004) 1.10
Helical tomotherapy as a new treatment technique for whole abdominal irradiation. Strahlenther Onkol (2008) 1.09
Intensity modulated radiotherapy in the management of sacral chordoma in primary versus recurrent disease. Radiother Oncol (2010) 1.09
Organ-, inflammation- and cancer specific transcriptional fingerprints of pancreatic and hepatic stellate cells. Mol Cancer (2010) 1.09
Intraoperative electron-beam therapy for primary and recurrent retroperitoneal soft-tissue sarcoma. Int J Radiat Oncol Biol Phys (2006) 1.08
Treatment of pediatric patients and young adults with particle therapy at the Heidelberg Ion Therapy Center (HIT): establishment of workflow and initial clinical data. Radiat Oncol (2012) 1.08
Treatment of cerebral metastases from breast cancer with stereotactic radiosurgery. Strahlenther Onkol (2004) 1.07
Enhancement of radiation response in osteosarcoma and rhabdomyosarcoma cell lines by histone deacetylase inhibition. Int J Radiat Oncol Biol Phys (2010) 1.07
Low rectal toxicity after dose escalated IMRT treatment of prostate cancer using an absorbable hydrogel for increasing and maintaining space between the rectum and prostate: results of a multi-institutional phase II trial. Radiother Oncol (2013) 1.07
Management of acoustic neuromas with fractionated stereotactic radiotherapy (FSRT): long-term results in 106 patients treated in a single institution. Int J Radiat Oncol Biol Phys (2005) 1.06
Heidelberg Ion Therapy Center (HIT): Initial clinical experience in the first 80 patients. Acta Oncol (2010) 1.06
Assessment of early toxicity and response in patients treated with proton and carbon ion therapy at the Heidelberg ion therapy center using the raster scanning technique. Int J Radiat Oncol Biol Phys (2011) 1.06
The stability of osseous metastases of the spine in lung cancer--a retrospective analysis of 338 cases. Radiat Oncol (2013) 1.05
Stereotactic intensity modulated radiation therapy and inverse treatment planning for tumors of the head and neck region: clinical implementation of the step and shoot approach and first clinical results. Radiother Oncol (2003) 1.05
Dynamic jaws and dynamic couch in helical tomotherapy. Int J Radiat Oncol Biol Phys (2009) 1.05
Intensity-modulated radiotherapy for complex-shaped meningioma of the skull base: long-term experience of a single institution. Int J Radiat Oncol Biol Phys (2007) 1.05
Comparison of arterial spin-labeling techniques and dynamic susceptibility-weighted contrast-enhanced MRI in perfusion imaging of normal brain tissue. Invest Radiol (2003) 1.04
Radiochemotherapy with temozolomide as re-irradiation using high precision fractionated stereotactic radiotherapy (FSRT) in patients with recurrent gliomas. J Neurooncol (2008) 1.03
Chemoradiation in patients with isolated recurrent pancreatic cancer - therapeutical efficacy and probability of re-resection. Radiat Oncol (2013) 1.03
Non-randomized therapy trial to determine the safety and efficacy of heavy ion radiotherapy in patients with non-resectable osteosarcoma. BMC Cancer (2010) 1.02
Outcome and prognostic factors of radiation therapy for medulloblastoma. Int J Radiat Oncol Biol Phys (2011) 1.02
Temozolomide combined with irradiation as postoperative treatment of primary glioblastoma multiforme. Phase I/II study. Strahlenther Onkol (2005) 1.02
Carbon ion radiotherapy for pediatric patients and young adults treated for tumors of the skull base. Cancer (2009) 1.02
Effect of radiotherapy and hyperthermia on the tumor accumulation of HPMA copolymer-based drug delivery systems. J Control Release (2006) 1.02
Highly effective treatment of skull base chordoma with carbon ion irradiation using a raster scan technique in 155 patients: first long-term results. Cancer (2014) 1.02
Randomised trial of proton vs. carbon ion radiation therapy in patients with chordoma of the skull base, clinical phase III study HIT-1-Study. BMC Cancer (2010) 1.01
Efficacy and toxicity of whole brain radiotherapy in patients with multiple cerebral metastases from malignant melanoma. Radiat Oncol (2012) 1.01
Clinical results of retreatment of vertebral bone metastases by stereotactic conformal radiotherapy and intensity-modulated radiotherapy. Int J Radiat Oncol Biol Phys (2003) 1.01
Quantification of lung tumor volume and rotation at 3D dynamic parallel MR imaging with view sharing: preliminary results. Radiology (2006) 1.01
Local high-dose radiotherapy and sparing of normal tissue using intensity-modulated radiotherapy (IMRT) for mucosal melanoma of the nasal cavity and paranasal sinuses. Strahlenther Onkol (2007) 1.01
Improved correlation of the neuropathologic classification according to adapted world health organization classification and outcome after radiotherapy in patients with atypical and anaplastic meningiomas. Int J Radiat Oncol Biol Phys (2010) 1.01
Carbon ion radiotherapy performed as re-irradiation using active beam delivery in patients with tumors of the brain, skull base and sacral region. Radiother Oncol (2010) 1.01
Intensity Modulated Radiotherapy (IMRT) and Fractionated Stereotactic Radiotherapy (FSRT) for children with head-and-neck-rhabdomyosarcoma. BMC Cancer (2007) 1.00
Treatment decision-making in localized prostate cancer: why patients chose either radical prostatectomy or external beam radiation therapy. BJU Int (2011) 0.99
Prognostic significance of IDH-1 and MGMT in patients with glioblastoma: one step forward, and one step back? Radiat Oncol (2011) 0.99
In vitro responsiveness of glioma cell lines to multimodality treatment with radiotherapy, temozolomide, and epidermal growth factor receptor inhibition with cetuximab. Int J Radiat Oncol Biol Phys (2007) 0.98
Combined treatment of nonsmall cell lung cancer NSCLC stage III with intensity-modulated RT radiotherapy and cetuximab: the NEAR trial. Cancer (2011) 0.98
Erythropoietin and G-CSF receptors in human tumor cells: expression and aspects regarding functionality. Tumori (2002) 0.98
Generation and validation of a prognostic score to predict outcome after re-irradiation of recurrent glioma. Acta Oncol (2012) 0.98
Feasibility and toxicity of combined photon and carbon ion radiotherapy for locally advanced adenoid cystic carcinomas. Int J Radiat Oncol Biol Phys (2003) 0.98
Evaluating target coverage and normal tissue sparing in the adjuvant radiotherapy of malignant pleural mesothelioma: helical tomotherapy compared with step-and-shoot IMRT. Radiother Oncol (2008) 0.98
Fractionated stereotactic radiation therapy in the management of benign cavernous sinus meningiomas : long-term experience and review of the literature. Strahlenther Onkol (2006) 0.97
Neuropsychological outcome after fractionated stereotactic radiotherapy (FSRT) for base of skull meningiomas: a prospective 1-year follow-up. Radiother Oncol (2003) 0.97
The effect of amifostine or IMRT to preserve the parotid function after radiotherapy of the head and neck region measured by quantitative salivary gland scintigraphy. Radiother Oncol (2008) 0.97
Long-term outcome after radiotherapy in patients with atypical and malignant meningiomas--clinical results in 85 patients treated in a single institution leading to optimized guidelines for early radiation therapy. Int J Radiat Oncol Biol Phys (2011) 0.97
The use of the multislice CT for the determination of respiratory lung tumor movement in stereotactic single-dose irradiation. Strahlenther Onkol (2003) 0.97